People · Operator
Named in public records as an officer, director or promoter · active 2019–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Emulate, Inc. | — | Biotechnology | Series C | $182.3M | $1.5B | 2020 |
| IsoPlexis Corp | — | Other Technology | Series C | $127.0M | $2.3B | 2020 |
| 908 Devices Inc. | — | Other Technology | Series B | $68.2M | $533.0M | 2019 |
Sharon Kedar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sharon Kedar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Egholm | 2 | 3 |
| Christopher Brown | 1 | 16 |
| Daniel Wagner | 1 | 13 |
| Keith Crandell | 1 | 11 |
| Mark Spoto | 1 | 8 |
| ERIC MOESSINGER | 1 | 6 |
| James Heath | 1 | 5 |
| John Conley | 1 | 5 |
| Gregory Ho | 1 | 4 |
| Donald Ingber | 1 | 3 |
| Nicholas Barthelemy | 1 | 3 |
| James Corbett | 1 | 3 |
| Martin Madaus | 1 | 3 |
| Aaron VanDevender | 1 | 3 |
| Shlomo Melmed | 1 | 3 |
| J. Michael Ramsey | 1 | 2 |
| Gregory D. Williams | 1 | 2 |
| Sean Mackay | 1 | 2 |
| Kevin Hrusovsky | 1 | 2 |
| Sean McKay | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.